GPT and delirium: In the iVori group, the ADRs included 33.3% (3/9) ALT elevation, 22.2% (2/9) delirium, 11.1% (1/9) hallucination, 11.1% (1/9) had headache, 11.1% (1/9) skin allergy and 11.1% (1/9) visual abnormalities, respectively.